Effect of an enteral amino acid blend on muscle and gut functionality in critically ill patients: a proof-of-concept randomized controlled trial.
Critical illness
Intensive care unit
Nutrition
Protein balance
Sepsis
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
17 11 2022
17 11 2022
Historique:
received:
10
08
2022
accepted:
21
10
2022
entrez:
18
11
2022
pubmed:
19
11
2022
medline:
22
11
2022
Statut:
epublish
Résumé
A defining feature of prolonged critical illness is muscle wasting, leading to impaired recovery. Supplementation with a tailored blend of amino acids may bolster the innate gut defence, promote intestinal mucosa repair and limit muscle loss. This was a monocentric, randomized, double-blind, placebo-controlled study that included patients with sepsis or acute respiratory distress syndrome. Patients received a specific combination of five amino acids or placebo mixed with enteral feeding for 21 days. Markers of renal function, gut barrier structure and functionality were collected at baseline and 1, 2, 3 and 8 weeks after randomization. Muscle structure and function were assessed through MRI measurements of the anterior quadriceps volume and by twitch airway pressure. Data were compared between groups relative to the baseline. Thirty-five critically ill patients were randomized. The amino acid blend did not impair urine output, blood creatinine levels or creatinine clearance. Plasma citrulline levels increased significantly along the treatment period in the amino acid group (difference in means [95% CI] 5.86 [1.72; 10.00] nmol/mL P = 0.007). Alanine aminotransferase and alkaline phosphatase concentrations were lower in the amino acid group than in the placebo group at one week (ratio of means 0.5 [0.29; 0.86] (P = 0.015) and 0.73 [0.57; 0.94] (P = 0.015), respectively). Twitch airway pressure and volume of the anterior quadriceps were greater in the amino acid group than in the placebo group 3 weeks after randomization (difference in means 10.6 [0.99; 20.20] cmH Amino acid supplementation increased plasma citrulline levels, reduced alanine aminotransferase and alkaline phosphatase levels, and improved twitch airway pressure and anterior quadriceps volume. Trial registration ClinicalTrials.gov, NCT02968836. Registered November 21, 2016.
Sections du résumé
BACKGROUND
A defining feature of prolonged critical illness is muscle wasting, leading to impaired recovery. Supplementation with a tailored blend of amino acids may bolster the innate gut defence, promote intestinal mucosa repair and limit muscle loss.
METHODS
This was a monocentric, randomized, double-blind, placebo-controlled study that included patients with sepsis or acute respiratory distress syndrome. Patients received a specific combination of five amino acids or placebo mixed with enteral feeding for 21 days. Markers of renal function, gut barrier structure and functionality were collected at baseline and 1, 2, 3 and 8 weeks after randomization. Muscle structure and function were assessed through MRI measurements of the anterior quadriceps volume and by twitch airway pressure. Data were compared between groups relative to the baseline.
RESULTS
Thirty-five critically ill patients were randomized. The amino acid blend did not impair urine output, blood creatinine levels or creatinine clearance. Plasma citrulline levels increased significantly along the treatment period in the amino acid group (difference in means [95% CI] 5.86 [1.72; 10.00] nmol/mL P = 0.007). Alanine aminotransferase and alkaline phosphatase concentrations were lower in the amino acid group than in the placebo group at one week (ratio of means 0.5 [0.29; 0.86] (P = 0.015) and 0.73 [0.57; 0.94] (P = 0.015), respectively). Twitch airway pressure and volume of the anterior quadriceps were greater in the amino acid group than in the placebo group 3 weeks after randomization (difference in means 10.6 [0.99; 20.20] cmH
CONCLUSIONS
Amino acid supplementation increased plasma citrulline levels, reduced alanine aminotransferase and alkaline phosphatase levels, and improved twitch airway pressure and anterior quadriceps volume. Trial registration ClinicalTrials.gov, NCT02968836. Registered November 21, 2016.
Identifiants
pubmed: 36397118
doi: 10.1186/s13054-022-04232-5
pii: 10.1186/s13054-022-04232-5
pmc: PMC9670468
doi:
Substances chimiques
Citrulline
29VT07BGDA
Creatinine
AYI8EX34EU
Alkaline Phosphatase
EC 3.1.3.1
Alanine Transaminase
EC 2.6.1.2
Banques de données
ClinicalTrials.gov
['NCT02968836']
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
358Informations de copyright
© 2022. The Author(s).
Références
N Engl J Med. 2014 Apr 10;370(15):1412-21
pubmed: 24635772
Clin Nutr. 2007 Feb;26(1):30-40
pubmed: 16996660
Chest. 2005 Jul;128(1):190-5
pubmed: 16002934
J Nutr. 2005 Mar;135(3):486-91
pubmed: 15735082
PLoS One. 2013 Nov 29;8(11):e81495
pubmed: 24312309
Neuromuscul Disord. 2017 Jun;27(6):518-525
pubmed: 28318818
Am J Physiol. 1992 Feb;262(2 Pt 1):C445-52
pubmed: 1371643
Clin Nutr. 2019 Feb;38(1):48-79
pubmed: 30348463
Nutr Clin Pract. 2021 Feb;36(1):40-49
pubmed: 33242218
Am J Respir Crit Care Med. 2010 Aug 15;182(4):446-54
pubmed: 20448093
Clin Nutr. 2015 Jun;34(3):335-40
pubmed: 25799486
Clin Nutr. 2004 Apr;23(2):273-80
pubmed: 15030968
Muscle Nerve. 1996 May;19(5):549-55
pubmed: 8618551
Resuscitation. 2013 Jan;84(1):60-5
pubmed: 22743354
Br J Anaesth. 2001 Dec;87(6):876-84
pubmed: 11878690
Intensive Care Med. 2017 Nov;43(11):1637-1647
pubmed: 28936712
Ann Surg. 1998 Aug;228(2):146-58
pubmed: 9712558
Lancet. 2009 May 30;373(9678):1874-82
pubmed: 19446324
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Stat Med. 1995 Sep 15;14(17):1933-40
pubmed: 8532986
Thorax. 1994 Dec;49(12):1234-7
pubmed: 7878560
J Nutr. 2000 May;130(5):1239-46
pubmed: 10801925
N Engl J Med. 2013 Apr 18;368(16):1489-97
pubmed: 23594003
Clin Nutr. 2006 Aug;25(4):634-42
pubmed: 16387396
JPEN J Parenter Enteral Nutr. 2016 Feb;40(2):159-211
pubmed: 26773077
J Nutr. 2006 Jun;136(6):1558-64
pubmed: 16702321
JPEN J Parenter Enteral Nutr. 2016 Aug;40(6):795-805
pubmed: 26635305
Intensive Care Med. 2009 Oct;35(10):1728-37
pubmed: 19572118
Crit Care Med. 2013 Oct;41(10):2298-309
pubmed: 23860247
Clin Nutr. 2008 Dec;27(6):793-9
pubmed: 18718696
J Appl Physiol (1985). 2007 Sep;103(3):739-46
pubmed: 17569771
Intensive Care Med. 2008 Nov;34(11):1980-90
pubmed: 18626628
Crit Care Med. 2021 Nov 1;49(11):e1063-e1143
pubmed: 34605781
Crit Care. 2014 Dec 14;18(6):701
pubmed: 25499096
Intensive Care Med. 2015 Jul;41(7):1197-208
pubmed: 25925203
Muscle Nerve. 2004 Sep;30(3):379-81
pubmed: 15318350
J Nutr. 2009 Apr;139(4):720-6
pubmed: 19193812
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
Lancet Respir Med. 2013 Oct;1(8):621-629
pubmed: 24461665
J Eval Clin Pract. 2004 May;10(2):307-12
pubmed: 15189396
Curr Opin Crit Care. 2017 Apr;23(2):143-148
pubmed: 28092310
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Eur Respir J Suppl. 1993 Mar;16:5-40
pubmed: 8499054
N Engl J Med. 2011 Aug 11;365(6):506-17
pubmed: 21714640
Crit Care. 2018 Oct 25;22(1):261
pubmed: 30360760
Clin Sci (Lond). 1998 Apr;94(4):413-23
pubmed: 9640347
J Crit Care. 2014 Apr;29(2):315.e1-6
pubmed: 24360391
JAMA. 2013 Oct 16;310(15):1591-600
pubmed: 24108501
Am J Physiol. 1991 Feb;260(2 Pt 1):E326-9
pubmed: 1996635
Br Med J (Clin Res Ed). 1981 Jan 31;282(6261):351-4
pubmed: 6780020
Front Nutr. 2019 Nov 29;6:181
pubmed: 31850360
PLoS One. 2011 Mar 31;6(3):e18090
pubmed: 21483870
JAMA. 2014 Aug 6;312(5):514-24
pubmed: 25096691
J Nutr. 2011 Aug;141(8):1432-6
pubmed: 21677074
Nutr Clin Pract. 2017 Apr;32(1_suppl):30S-47S
pubmed: 28388380
PLoS One. 2015 Apr 07;10(4):e0121933
pubmed: 25849571